The role of the nuclear matrix in cancer chemotherapy

Critical Reviews in Eukaryotic Gene Expression

Volumn 9, Issue 3-4, 1999, Pages 337-343

  Muenchen, H J ^a   Pienta, K J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Alkylating agents; Anticancer agents; Antimetabolites; Ionizing radiation; Topoisomerase I; Topoisomerase II

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; DNA PRIMASE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING);

CANCER CHEMOTHERAPY; CELL DEATH; CELL NUCLEUS MATRIX; CHROMATIN; CROSS LINKING; DNA SYNTHESIS; IONIZING RADIATION; MALIGNANT TRANSFORMATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REVIEW; RNA PROCESSING;

EID: 0033391962     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.v9.i3-4.180     Document Type: Review

References (35)

1. Adachi Y, Kas E, Laemmli UK (1989): Preferential cooperative binding of DNA topoisomerase II to scaffold-association regions. EMBO J 8:3997-4006.
2. Baldini N, Scotland; K, Serra M, Shikita T, Zini N, Ognibene A, Santi S, Ferracini R, Maraldi NM (1995): Nuclear immobilization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur J Cell Biol 68:226-239.
3. Berezney R (1984): Organization and functions of the nuclear matrix. In Hnilica LS (ed): "Chromosomal Nonhistone Proteins." Boca Raton, FL: CRC Press, 119-180.
4. Briggs JA, Briggs RC (1988): Characterization of chromium effects on a rat liver epithelial cell line and their relevance to in vitro transformation. Cancer Res 48:6484-6490.
5. Champoux JJ, Dulbecco R (1972): An activity from mammalian cells that untwists superhelical DNA - a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay). Proc Natl Acad Sci USA 69:143-146.
6. Chiu S-M, Oleinick N (1982): The sensitivity of active and inactive chromatin to ionizing radiation-induced DNA strand breakage. Int J Radiat Biol 41:71-77.
7. Cook PR, Brazell IA (1976): Conformational constraints in nuclear DNA. J Cell Sci 22:287-302.
8. Danks MK, Yalowich JC, Beck WT (1987): Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide. Cancer Res 47:1297-1301.
9. Del Bino G, Skierski JS, Darzynkiewicz Z (1991): The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195:485-491.
10. DiNardo S, Voelkel K, Sternglanz R (1984): DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 81:2616-2620.
11. Egly JM, Miyamoto NG, Moncollin V, Chambon P (1984): Is actin a transcription initiation factor for RNA polymerase B? EMBO J 3:2363-2371.
12. Fernandes DJ, Catapano CV (1995): The nuclear matrix as a site of anticancer drug action. Int Rev Cytol 162A: 539-576.
13. Fernandes DJ, Qui J, Catapano CV (1995a): DNA topoisomerase II isozymes involved in anticancer drug action and resistance. Adv Enzyme Regul 35:265-281.
14. Getzenburg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR (1996): Bladder cancer-associated nuclear matrix proteins. Cancer Res 56:1690-1694.
15. Getzenburg RH, Pienta KJ, Ward WS, Coffey DS (1991): Nuclear structure and three-dimensional organization of DNA. J Cell Biochem 47:289-299.
16. Kas E, Poljak L, Adachi Y, Laemmli UK (1993): A model for chromatin opening: Stimulation of topoisomerase II and restriction enzyme cleavage by chromatin by distamycin. EMBO J 12:115-126.
17. Kohn KW (1977): Interstrand cross-linking of DNA by 1,3-bis(2-chlorethyl)-1-nitrosourea and other 1-(2-haloethy)-1-nitrosoureas. Cancer Res 37:1450-1454.
18. Luderus MEE, den Blaauwen JL, de Smit OJB, Compton DA, van Driel R (1994): Binding of matrix attachment regions of lamin polymers involves single stranded regions and the minor groove. Mol Cell Biol 14:6297-6305.
19. Miller CA III, Cohen MD, Costa M (1991): Complexing of actin and other nuclear proteins to DNA by cisdiamminedichloroplatinum (II) and chromium compounds. Carcinogenesis 12:269-276.
20. Mirkovitch J, Mirault ME, Laemmli UK (1984): Organization of the higher order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39:223-232.
21. Montgomery JA, James R, McCaleb GS, Johnston TP (1967): The modes of decomposition of 1,3-bis-2-chlorethy-1-nitrosourea and related compounds. J Med Chem 10: 668-674.
22. Nelson WG, Liu LF, Coffey DS (1986): Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature 322: 187-189.
23. Nickerson JA (1998): Nuclear dreams: the malignant alteration of nuclear architecture. J Cell Biochem 70: 172-180.
24. Osheroff N (1989): Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Biochemistry 28:6157-6160.
25. Pienta KJ, Lehr JE (1993): Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix. J Urol 149:1622-1625.
26. Pienta KJ, Partin AW, Coffey DS (1989): Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49:2525-2532.
27. Rose D, Thomas W, Holm C (1990): Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II. Cell 60:1009-1017.
28. Tan KB, Mattern MR, Boyce RA, Schein PS (1987): Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. Proc Natl Acad Sci USA 84: 7668-7671.
29. Taudou G, Mirambeau G, Lavenot C, der Garabedian A, Vermeersch J, Duguet M (1984): DNA topoisomerase activities in concanavalin A-stimulated lymphocytes. FEBS Lett 176:431-435.
30. Tew KD, Erickson K, White G, Wang AL, Schein PS, Hartley-Asp B (1983): Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets. Mol Pharmacol 24:324-328.
31. Vogelstein B, Pardoll DM, Coffey DS (1980): Supercoiled loops and eukaryotic DNA replication. Cell 22:79-85.
32. Wang JC (1985): DNA topoisomerases. Ann Rev Biochem 54:665-697.
33. Yang C-P, Goei de Pinho S, Greenberger LM, Arceci RJ, Horwitz SB (1989): Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264:782-788.
34. Zwelling LA, Kerrigan D, Marton LJ (1985): Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4′-(9-acridinylamino)methane-sulfon-m-anisidide in L1210 murine leukemia cells. Cancer Metastasis Rev 4:263-276.
35. Zweyer M, Riederer BM, Ochs RL, Fackelmeyer FO, Kohwi-Shigematsu T, Bareggi R, Narducci P, Martelli AM (1997): Association of nuclear matrix proteins with granular and threaded nuclear bodies in cell lines undergoing apoptosis. Exp Cell Res 230:325-336.